Substituted thiophene derivatives as glucagon receptor antagonists, preparation and therapeutic uses

Details for Australian Patent Application No. 2006213894 (hide)

Owner Eli Lilly and Company

Inventors Chappell, Mark Donald; Tripp, Allie Edward; Conner, Scott Eugene; Zhu, Guoxin

Agent Spruson & Ferguson

Pub. Number AU-B-2006213894

PCT Pub. Number WO2006/086488

Priority 60/652,492 11.02.05 US

Filing date 9 February 2006

Wipo publication date 17 August 2006

Acceptance publication date 8 December 2011

International Classifications

C07D 333/24 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

A61K 31/381 (2006.01) - having five-membered rings

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

2 August 2007 PCT application entered the National Phase

  PCT publication WO2006/086488 Priority application(s): WO2006/086488

8 December 2011 Application Accepted

  Published as AU-B-2006213894

5 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006213907-Key probe compositions and methods for polynucleotide detection

2006213890-Meleimide derivatives, pharmaceutical compositions and methods for treatment of cancer